BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 20339031)

  • 1. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
    Xu R; Ekiert DC; Krause JC; Hai R; Crowe JE; Wilson IA
    Science; 2010 Apr; 328(5976):357-60. PubMed ID: 20339031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swine flu pandemic. What's old is new: 1918 virus matches 2009 H1N1 strain.
    Cohen J
    Science; 2010 Mar; 327(5973):1563-4. PubMed ID: 20339037
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody recognition of a highly conserved influenza virus epitope.
    Ekiert DC; Bhabha G; Elsliger MA; Friesen RH; Jongeneelen M; Throsby M; Goudsmit J; Wilson IA
    Science; 2009 Apr; 324(5924):246-51. PubMed ID: 19251591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.
    Strengell M; Ikonen N; Ziegler T; Julkunen I
    PLoS One; 2011; 6(10):e25848. PubMed ID: 22022458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.
    Hong M; Lee PS; Hoffman RM; Zhu X; Krause JC; Laursen NS; Yoon SI; Song L; Tussey L; Crowe JE; Ward AB; Wilson IA
    J Virol; 2013 Nov; 87(22):12471-80. PubMed ID: 24027321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.
    Wyrzucki A; Dreyfus C; Kohler I; Steck M; Wilson IA; Hangartner L
    J Virol; 2014 Jun; 88(12):7083-92. PubMed ID: 24719426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin.
    Igarashi M; Ito K; Yoshida R; Tomabechi D; Kida H; Takada A
    PLoS One; 2010 Jan; 5(1):e8553. PubMed ID: 20049332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a high affinity neutralizing monoclonal antibody against 2009 pandemic H1N1 virus that binds at the 'Sa' antigenic site.
    Shembekar N; Mallajosyula VV; Mishra A; Yeolekar L; Dhere R; Kapre S; Varadarajan R; Gupta SK
    PLoS One; 2013; 8(1):e55516. PubMed ID: 23383214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
    Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
    PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
    Schmeisser F; Friedman R; Besho J; Lugovtsev V; Soto J; Wang W; Weiss C; Williams O; Xie H; Ye Z; Weir JP
    Influenza Other Respir Viruses; 2013 May; 7(3):480-90. PubMed ID: 23122228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.
    Wei CJ; Boyington JC; Dai K; Houser KV; Pearce MB; Kong WP; Yang ZY; Tumpey TM; Nabel GJ
    Sci Transl Med; 2010 Mar; 2(24):24ra21. PubMed ID: 20375007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Haveri A; Ikonen N; Kantele A; Anttila VJ; Ruotsalainen E; Savolainen-Kopra C; Julkunen I
    Vaccine; 2019 May; 37(20):2731-2740. PubMed ID: 30954308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.
    Castrucci MR; Facchini M; Di Mario G; Garulli B; Sciaraffia E; Meola M; Fabiani C; De Marco MA; Cordioli P; Siccardi A; Kawaoka Y; Donatelli I
    Influenza Other Respir Viruses; 2014 May; 8(3):367-75. PubMed ID: 24373385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
    Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y
    Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.
    Krause JC; Tumpey TM; Huffman CJ; McGraw PA; Pearce MB; Tsibane T; Hai R; Basler CF; Crowe JE
    J Virol; 2010 Mar; 84(6):3127-30. PubMed ID: 20042511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
    Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
    Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.
    Liu X; Liu Y; Zhang Y; Chen Z; Tang Z; Xu Q; Wang Y; Zhao P; Qi Z
    PLoS One; 2013; 8(3):e58810. PubMed ID: 23527030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells.
    Lee CC; Yang CY; Lin LL; Ko TP; Chang AH; Chang SS; Wang AH
    Sci Rep; 2019 Mar; 9(1):4546. PubMed ID: 30872685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influenza virus hemagglutinin head evolves faster than the stalk domain.
    Kirkpatrick E; Qiu X; Wilson PC; Bahl J; Krammer F
    Sci Rep; 2018 Jul; 8(1):10432. PubMed ID: 29992986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.